Meclizine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for meclizine hydrochloride and what is the scope of freedom to operate?
Meclizine hydrochloride
is the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Apnar Pharma Lp, Aurobindo Pharma Usa, Bundy, Chartwell Rx, Epic Pharma Llc, Invatech, Jubilant Cadista, Kv Pharm, Rising, Sandoz, Strides Pharma, Superpharm, UDL, Vangard, Watson Labs, and Zydus Lifesciences, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for meclizine hydrochloride. Thirty-three suppliers are listed for this compound.
Summary for meclizine hydrochloride
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 25 |
NDAs: | 38 |
Drug Master File Entries: | 9 |
Finished Product Suppliers / Packagers: | 33 |
Raw Ingredient (Bulk) Api Vendors: | 182 |
Clinical Trials: | 10 |
Patent Applications: | 6,780 |
What excipients (inactive ingredients) are in meclizine hydrochloride? | meclizine hydrochloride excipients list |
DailyMed Link: | meclizine hydrochloride at DailyMed |
Recent Clinical Trials for meclizine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | Phase 1/Phase 2 |
Hospital Federal de Bonsucesso | Phase 4 |
Yvonne Sada | Phase 1 |
Pharmacology for meclizine hydrochloride
Drug Class | Antiemetic |
Physiological Effect | Emesis Suppression |
Medical Subject Heading (MeSH) Categories for meclizine hydrochloride
US Patents and Regulatory Information for meclizine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abc Holding | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 085252-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Kv Pharm | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 085523-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Kv Pharm | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 085524-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.